| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $96.2M | +85.0% |
| Cost of Revenue | $80.9M | +109.9% |
| Gross Profit | $15.3M | +13.6% |
| R&D Expense | $3.2M | +51.1% |
| SG&A Expense | $25.1M | +16.3% |
| Operating Income | -$46.2M | -50.5% |
| Pre-tax Income | -$55.6M | -75.6% |
| Income Tax | -$55K | +0.0% |
| Net Income | -$48.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $21.3M | +29.6% |
| Current Assets | $36.5M | +64.0% |
| Total Assets | $78.7M | +21.7% |
| Current Liabilities | $54.8M | +51.4% |
| Total Liabilities | $66.7M | +44.0% |
| Stockholders' Equity | $12.0M | -34.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.6M | -90.1% |
| Capital Expenditures | $5K | +128.5% |
| Investing Cash Flow | $2.7M | -80.8% |
| Financing Cash Flow | $38.0M | +860.2% |
| Free Cash Flow | -$30.6M | -90.1% |
| -55.8% |
| EPS (Basic) | -$1.75 | +37.7% |
| EPS (Diluted) | -$1.75 | +37.7% |